about
Development of enantioselective synthetic routes to (-)-kinamycin F and (-)-lomaiviticin aglycon.Persisters, persistent infections and the Yin-Yang model.Blocking NOTCH Pathway can Enhance the Effect of EGFR Inhibitor through Targeting CD133+ Endometrial Cancer Cells.Overcoming Ovarian Cancer Drug Resistance with a Cold Responsive Nanomaterial.
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Preclinical development of cancer stem cell drugs.
@en
type
label
Preclinical development of cancer stem cell drugs.
@en
prefLabel
Preclinical development of cancer stem cell drugs.
@en
P2860
P1476
Preclinical development of cancer stem cell drugs.
@en
P2093
Jiangbing Zhou
Ying Zhang
P2860
P304
P356
10.1517/17460440903002059
P407
P577
2009-06-09T00:00:00Z